Keywords: novel, treatment, breast, cancer, phase, ii, studies

NOVEL TREATMENT FOR BREAST CANCER

Article | 02 November 1992

Print This

- Phase II studies of a novel treatment for breast cancer, KM2210, suggest that the agent has a response rate of 27.2% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in